|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.041 DKK | +7.89% |
|
-10.48% | +36.67% |
| 18/06 | DanCann Pharma A/S Provides Revenue Guidance for the Year 2024 | CI |
| 01/06 | DanCann Pharma A/S Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
DanCann Pharma A/S reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was DKK 7.15 million compared to DKK 8.68 million a year ago. Net loss was DKK 12.34 million compared to DKK 16.54 million a year ago.
Basic loss per share from continuing operations was DKK 0.09 compared to DKK 0.58 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +36.67% | 10L | |
| +15.20% | 12TCr | |
| +19.67% | 11TCr | |
| +18.95% | 2.6TCr | |
| -23.86% | 1.94TCr | |
| -19.03% | 1.59TCr | |
| -20.90% | 1.51TCr | |
| -46.14% | 1.51TCr | |
| +63.85% | 1.49TCr | |
| +4.49% | 1.39TCr |
DANCANN PHARMA A/S 
